CTO21042GZA: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial (clinicaltrialsregister.eu) - May 14, 2026 - P2/3 | N=493 | Recruiting | Sponsor: Ziekenhuis Aan De Stroom
New P2/3 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|